What is the treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Impetigo

For impetigo treatment, topical antibiotics (mupirocin 2% ointment or retapamulin 1% ointment) are recommended as first-line therapy for limited lesions, while oral antibiotics are indicated for extensive disease, impractical topical therapy, treatment failure, or systemic symptoms. 1

First-Line Treatment: Topical Antibiotics

  • Mupirocin 2% ointment should be applied to affected areas three times daily for 5-7 days for limited impetigo lesions 1, 2
  • Retapamulin 1% ointment is an effective alternative, applied twice daily for 5 days 1, 3
  • Topical antibiotics have shown better cure rates than placebo (risk ratio 2.24) and are associated with fewer side effects than oral antibiotics 4
  • The treated area may be covered with a sterile bandage or gauze dressing if desired 3

Second-Line Treatment: Oral Antibiotics

  • Oral antibiotics are recommended for:
    • Extensive disease
    • Cases where topical therapy is impractical
    • Failure of topical treatment
    • Presence of systemic symptoms 1
  • Recommended oral antibiotics include:
    • Dicloxacillin
    • First-generation cephalosporins (e.g., cephalexin) 1
  • Complete the full course of prescribed antibiotics even if symptoms improve quickly to ensure complete resolution and prevent complications 1

Special Considerations for MRSA

  • Consider empiric therapy for community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in:
    • Patients at risk for CA-MRSA infection
    • Cases with failure to respond to first-line therapy
    • Areas with high local prevalence of CA-MRSA 1
  • Treatment options for suspected CA-MRSA include:
    • Trimethoprim-sulfamethoxazole
    • Clindamycin
    • Doxycycline 1, 5

Important Clinical Pearls

  • Impetigo is highly contagious and most commonly affects children 2-5 years of age 1, 5
  • Causative organisms include Staphylococcus aureus and/or Streptococcus pyogenes 1, 5
  • Retapamulin is indicated only for methicillin-susceptible S. aureus, not MRSA 3
  • Discontinue topical treatment in the event of sensitization or severe local irritation 3
  • Topical disinfectants are inferior to antibiotics and should not be used 5, 6
  • Monitor for increasing bacterial resistance, particularly to macrolides and mupirocin 5
  • Most cases resolve within 2-3 weeks without scarring when properly treated 5
  • Potential complications, though rare, include post-streptococcal glomerulonephritis 1, 5

References

Guideline

Treatment of Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.